Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.88 USD
Change Today +0.08 / 1.18%
Volume 6.4K
CPIX On Other Exchanges
As of 4:00 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

A. J. Kazimi MBA

Founder, Chairman, Chief Executive Officer and President, Cumberland Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 58 board members in 4 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. A. J. Kazimi, MBA founded Cumberland Pharmaceuticals Inc. in 1999 and has been its Chairman and Chief Executive Officer since 1999. Mr. Kazimi serves as the President of Cumberland Pharmaceuticals, Inc. and served as its Principal Financial Officer since April 4, 2011. He is the Founder of Cumberland Emerging Technologies, a subsidiary of Cumberland Pharmaceuticals Inc. and serves as its Chief Executive Officer. He has 20 years career in the biopharmaceutical industry. ...

Read Full Background

Corporate Headquarters*

2525 West End Avenue
Nashville, Tennessee 37203

United States

Phone: 615-255-0068
Fax: 615-255-0094

Board Members Memberships*

Founder, Chairman, Chief Executive Officer and President
Former President, Chief Operating Officer and Director


Bachelor's Degree
University of Notre Dame
University of Notre Dame
Unknown/Other Education
School of Medicine, Vanderbilt University
Owen School of Management, Vanderbilt University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$650,000

Stock Options*

Restricted Stock Awards$343,500
All Other Compensation$2,450

Total Compensation*

Total Annual Cash Compensation$652,450
Total Short Term Compensation$650,000
Other Long Term Compensation$345,950
Total Calculated Compensation$995,950
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CPIX:US $6.88 USD +0.08


David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
Rajat Rai Chief Executive Officer
Akorn, Inc.
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CUMBERLAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at